Aug.  26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is combining the power of targeted drugs and ultra-sound technology to shrink the tumors of patients whose cancer has not spread to other parts of the body but is too advanced to allow safe surgical removal.

American Society for Radiation Oncology (ASTRO) 67th Annual Meeting

HIMSS Global Health Conference & Exhibition

Aug. 26, 2025— Esaote North America, Inc., a provider of dedicated MRI, Ultrasound, and Healthcare IT solutions, has announced a strategic partnership with Epica International, a global provider in advanced CT and imaging technologies. This collaboration unites two complementary portfolios to expand market presence and accelerate the adoption of high-performance MRI and CT solutions across the human and veterinary healthcare sectors.

Aug. 27,  2025 – Qureight recently announced that it has been selected by Calluna Pharma to support its Phase 2 AURORA study. Qureight will analyze imaging data from adult patients, evaluating anatomical lung changes in individuals treated with CAL101, Calluna’s lead asset for the treatment of idiopathic pulmonary fibrosis (IPF).

Aug. 27, 2025 — Bayer has announced that a New Drug Application (NDA) for its investigational contrast agent gadoquatrane has been accepted for review by the U.S. Food and Drug Administration (FDA). The NDA for gadoquatrane has been filed for contrast-enhanced magnetic resonance imaging of the CNS and other body regions in adults and pediatric patients, including neonates.

Aug. 26, 2025 — Core Sound Imaging, the company behind the widely established Studycast medical imaging workflow platform, has acquired UltraLinQ Healthcare Solutions, a provider of cloud-based PACS and cardiac monitoring solutions. This platform expansion is part of Studycast's strategic growth initiative to consolidate strong imaging solutions under one robust platform.

Aug. 21, 2025 — On Aug. 21, 2025, Nusano, a physics company transforming the production of radioisotopes, cut the ribbon on its 190,000-square-foot radioisotope production facility in West Valley City, Utah. The site will be capable of producing more than 40 different radioisotopes for use in cancer diagnostics and therapeutics, as well as industrial applications, such as long-lived nuclear batteries.

Aug. 26, 2025 — Optellum, a global leader in AI for lung health, recently announced the world’s first thorax CT foundation model built for precision lung care in real-world settings — an ambitious initiative aiming to revolutionize the early detection and management of lung diseases, with an initial focus on lung cancer.

Aug. 21, 2025 — The medical imaging market is projected to have a compound annual growth rate of nearly six percent over the next seven years.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now